Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report07 April 2020
Protecting the health, safety and wellbeing of the communities where we operate, as well as our employees, is of primary importance to Urenco at all times, and especially during the COVID-19 pandemic.
In addition to the preventative and mitigation efforts we have in place to ensure we can continue to play our part in providing reliable power generation during this time, we are sharing personal protective equipment with health workers in care homes, hospitals and other medical organisations.
This has been supported by a generous gift from one of our customers, who kindly donated a large number of protective face masks to Urenco to show their support and friendship at this difficult time.
The masks are being distributed among our employees and seven critical medical organisations, and have been supplemented by overalls and aprons donated by Urenco’s sites.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries